In CommitteeFiled Feb 12, 2026
Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] (R)
Latest Action
Referred to the House Committee on Energy and Commerce.
Feb 12, 2026
Summary
The GAP Supply Act amends the Federal Food, Drug, and Cosmetic Act so that outsourcing facilities can continue to compound and distribute drugs for a short “tail” period after a shortage is declared. This gives hospitals and patients a longer window to obtain needed medicines while the market stabilizes. It targets the supply chain gap that can leave patients without critical therapies.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 7528 changes status, plus AI-powered summaries and stage predictions.
Sign up free